These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 6798100)

  • 1. Mechanisms of action of sucralfate.
    Nagashima R
    J Clin Gastroenterol; 1981; 3(Suppl 2):117-27. PubMed ID: 6798100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of food and antacid on binding of sucralfate to normal and ulcerated gastric and duodenal mucosa in rats.
    Giesing DH; Bighley LD; Iles RL
    J Clin Gastroenterol; 1981; 3(Suppl 2):111-6. PubMed ID: 6895642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sucralfate: development of a new concept of anti-ulcer treatment. Review of its pharmacodynamic properties].
    Gorget C
    Rev Med Interne; 1985 Jun; 6(3):313-9. PubMed ID: 3901171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sucralfate (Ulcogant). The mechanism of action of a cytoprotective agent].
    Steiner KF
    Fortschr Med; 1983 Dec; 101(47-48):2197-200concl. PubMed ID: 6423500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and characteristics of sucralfate.
    Nagashima R
    J Clin Gastroenterol; 1981; 3(Suppl 2):103-10. PubMed ID: 6798099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sucralfate protection of the gastric mucosa against ethanol-induced injury: a prostaglandin-mediated process?
    Hollander D; Tarnawski A; Gergely H; Zipser RD
    Scand J Gastroenterol Suppl; 1984; 101():97-102. PubMed ID: 6599542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sucralfate: antipeptic, antiulcer activities and antagonism of gastric emptying.
    Borella LE; Seethaler K; Lippmann W
    Arzneimittelforschung; 1979; 29(5):793-8. PubMed ID: 387045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sucralfate--alternative therapy for peptic-ulcer disease.
    Garnett WR
    Clin Pharm; 1982; 1(4):307-14. PubMed ID: 6764389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mechanism of protective, therapeutic and prophylactic actions of sucralfate.
    Tarnawski A; Hollander D; Gergely H
    Scand J Gastroenterol Suppl; 1987; 140():7-13. PubMed ID: 3481883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of an antiulcer drug, sucralfate (a basic aluminum salt of sulfated disaccharide), on experimental gastric lesions and gastric secretion in rats.
    Okabe S; Takeuchi K; Kunimi H; Kanno M; Kawashima M
    Dig Dis Sci; 1983 Nov; 28(11):1034-42. PubMed ID: 6688779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The protective effect of sucralfate on the gastric mucosa of rats.
    Harrington SJ; Schlegel JF; Code CF
    J Clin Gastroenterol; 1981; 3(Suppl 2):129-34. PubMed ID: 6895643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of peptic aggression by sucralfate. The view from the ulcer crater.
    Samloff IM
    Scand J Gastroenterol Suppl; 1983; 83():7-11. PubMed ID: 6415806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosa protectives: sucralfate and colloidal bismuth subcitrate in peptic ulcer disease.
    Tytgat GN; Nio CY
    Z Gastroenterol; 1987 Aug; 25 Suppl 3():152-61. PubMed ID: 3660894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental evaluation of Bocopa monniera on rat gastric ulceration and secretion.
    Rao CV; Sairam K; Goel RK
    Indian J Physiol Pharmacol; 2000 Oct; 44(4):435-41. PubMed ID: 11214498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-steroidal anti-inflammatory drug gastropathy: clinical results with antacids and sucralfate.
    Lazzaroni M; Sainaghi M; Bianchi Porro G
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S48-53. PubMed ID: 10379470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sucralfate. A review of its pharmacodynamic properties and therapeutic use in peptic ulcer disease.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1984 Mar; 27(3):194-209. PubMed ID: 6368184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SU-840, a novel synthetic flavonoid derivative of sophoradin, with potent gastroprotective and ulcer healing activity.
    Brzozowski T; Konturek SJ; Kwiecien S; Pajdo R; Drozdowicz D; Sliwowski Z; Muramatsu M
    J Physiol Pharmacol; 1998 Mar; 49(1):83-98. PubMed ID: 9594413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sucralfate: pharmacokinetics, metabolism and selective binding to experimental gastric and duodenal ulcers in animals.
    Steiner K; Bühring KU; Faro HP; Garbe A; Nowak H
    Arzneimittelforschung; 1982; 32(5):512-8. PubMed ID: 6896647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection of gastric mucosa by sucralfate from aspirin-induced erosions.
    Tesler MA; Lim ES
    J Clin Gastroenterol; 1981; 3(Suppl 2):175-9. PubMed ID: 6895645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy]propyl] urea with potent gastric mucosal protective activity on acute gastric lesions and duodenal ulcers in rats.
    Sekiguchi H; Hamada K; Taga F; Nishino K
    Arzneimittelforschung; 1993 Feb; 43(2):134-8. PubMed ID: 8096133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.